Closely watched arthritis drug disappoints in Covid-19 trial – The Star Online
- Closely watched arthritis drug disappoints in Covid-19 trial The Star Online
- After Remdesivir, second drug disappoints in Covid-19 trial New Straits Times Online
- Arthritis drug shows benefit for only the sickest of coronavirus patients, pushing drugmakers to narrow drug trial CNBC
- Coronavirus Treatment: Arthritis Drug Mixed In Covid-19; Gilead’s Remdesivir Considered In Japan Investor’s Business Daily
- Coronavirus treatment trial results for Regeneron and Sanofi’s Kevzara – Business Insider Business Insider
- View Full coverage on Google News
Source: Business News Feed